Bausch Health sues Amneal Pharma over Xifaxan generic [Seeking Alpha]
Bausch Health Companies Inc. (BHC)
Last bausch health companies inc. earnings: 2/19 06:59 am
Check Earnings Report
Company Research
Source: Seeking Alpha
In filing a lawsuit in a New Jersey District Court after Amneal ( AMRX ) sought U.S. approval for its product, Bausch Health ( BHC ) alleged that the company has infringed on certain Xifaxan patents listed in the FDA's Orange Book. "Bausch Health remains confident in its XIFAXAN intellectual property, and we will continue to defend our XIFAXAN franchise for the benefit of patients," CEO Thomas Appio noted in a statement late Friday. The lawsuit prevents a potential FDA approval of the product for 30 days. In 2020, Bausch Health ( BHC ) reached agreements with generic drugmakers, including Teva Pharmaceuticals ( TEVA ) and Novartis' ( NVS OTCPK:NVSEF ) spinoff Sandoz ( OTCQX:SDZNY OTCQX:SDZXF ) to settle patent disputes related to Xifaxan. Another legal dispute with privately held generic drugmaker Norwich Pharmaceuticals is ongoing. Recommended For You More Trending News Recommended For You More Trending News Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
BHC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BHC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BHC alerts
High impacting Bausch Health Companies Inc. news events
Weekly update
A roundup of the hottest topics
BHC
News
- Global $15.4 Billion Macular Degeneration Treatment Market, 2032: Modern Dietary Routines and Sedentary Lifestyles Driving the Incidence of Macular Degeneration [Yahoo! Finance]Yahoo! Finance
- Why Bausch Health Stock Plunged After Posting First-Quarter 2024 Results [Seeking Alpha]Seeking Alpha
- Bausch Health Companies (NYSE:BHC investor three-year losses grow to 72% as the stock sheds US$388m this past week [Yahoo! Finance]Yahoo! Finance
- Bausch Health Companies Inc. (NYSE:BHC) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- CANADA STOCKS-Toronto stocks rise on energy boost, rate-cut optimism [Yahoo! Finance]Yahoo! Finance
BHC
Earnings
- 5/2/24 - Miss
BHC
Sec Filings
- 5/2/24 - Form 10-Q
- 5/2/24 - Form 8-K
- 4/4/24 - Form ARS
- BHC's page on the SEC website